Skip to content
ET
Company

Updated:

Entasis Therapeutics Holdings Inc.

Entasis Therapeutics Holdings Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001724344, and its...

Overview

Entasis Therapeutics Holdings Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001724344, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-03-03, it reported net income of USD -47,141,000; total assets of USD 40,920,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Entasis Therapeutics Holdings Inc.
Former names in filing history
Entasis Therapeutics Ltd (2017-12-08 to 2018-08-17)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Waltham, MA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001724344

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2021USD—-$47.1M$40.9M$32.3M-$43.0M
FY2020USD—-$50.5M$61.6M$53.2M-$45.4M
FY2019USD$7.0M-$43.9M$51.0M$16.0M-$44.7M
FY2018USD$5.0M-$33.0M$89.3M$49.4M-$35.8M

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
8-KFORM 8-K
10-K/A10-K/A
10-Q10-Q
8-K8-K
10-K10-K
8-K8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
10-Q10-Q

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Entasis Therapeutics Holdings Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Entasis Therapeutics Holdings Inc. | Waltham Company | Altss